Nan Fung Group Holdings Ltd
An institutional investment manager in KAI TAK. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 1782539.
- Reported value$131.5m
- Positions25
Holdings: 25 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Maplight Therapeutics IncMPLT | COM | 56565P103 | 34.8 | 26.5% | 971,253 | Unchanged | |
| LB Pharmaceuticals IncLBRX | COM SHS | 50180M108 | 20.5 | 15.6% | 630,657 | Unchanged | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 19.2 | 14.6% | 1,441,032 | Unchanged | |
| Cybin Inc | COM NEW | 23256X407 | 6.5 | 5.0% | 987,222 | Added+527,222 | |
| Incyte CorpINCY | COM | 45337C102 | 6.1 | 4.6% | 53,742 | Unchanged | |
| Rhythm Pharmaceuticals IncRYTM | COM | 76243J105 | 5.5 | 4.1% | 49,120 | Unchanged | |
| Beone Medicines LtdONC | SPONSORED ADS | 07725L102 | 4.5 | 3.4% | 15,722 | Unchanged | |
| Oculis Holding AG | ORDINARY SHARES | H5870P102 | 4.2 | 3.2% | 300,565 | Reduced−50,180 | |
| Ascendis Pharma A/S | ORD SHS | K08588103 | 3.6 | 2.8% | 13,600 | New+13,600 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 3.6 | 2.7% | 19,253 | Unchanged | |
| Kymera Therapeutics IncKYMR | COM | 501575104 | 3.5 | 2.7% | 30,875 | Unchanged | |
| Madrigal Pharmaceuticals IncMDGL | COM | 558868105 | 3.0 | 2.3% | 5,672 | Unchanged | |
| Celcuity IncCELC | COM | 15102K100 | 3.0 | 2.3% | 28,300 | Unchanged | |
| Acadia Pharmaceuticals IncACAD | COM | 004225108 | 2.6 | 2.0% | 102,984 | Unchanged | |
| Argenx SEARGX | SPONSORED ADR | 04016X101 | 2.6 | 2.0% | 2,800 | Unchanged | |
| Recursion Pharmaceuticals inRXRX | CL A | 75629V104 | 2.2 | 1.7% | 595,287 | Unchanged | |
| Procore Technologies IncPCOR | COM | 74275K108 | 2.2 | 1.6% | 53,299 | Unchanged | |
| Harmony Biosciences Holdings inHRMY | COM | 413197104 | 1.0 | 0.7% | 27,049 | Unchanged | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 0.7 | 0.5% | 6,580 | Unchanged | |
| Ishares Ethereum TR | SHS | 46438R105 | 0.6 | 0.5% | 50,549 | Unchanged | |
| Ishares Bitcoin Trust ETFIBIT | SHS BEN INT | 46438F101 | 0.5 | 0.4% | 15,968 | Unchanged | |
| Chime Finl IncCHYM | COM SHS CL A | 16935C109 | 0.4 | 0.3% | 21,075 | New+21,075 | |
| Rani Therapeutics Holdings IncRANI | COM CL A | 753018100 | 0.4 | 0.3% | 493,584 | Unchanged | |
| Entrada Therapeutics IncTRDA | COM | 29384C108 | 0.4 | 0.3% | 49,082 | Unchanged | |
| Bolt Biotherapeutics IncBOLT | COM NEW | 097702203 | 0.0 | <0.1% | 5,000 | Reduced−24,250 |
Sold out: 1 position
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 0.0 | 0.0% | 0 | Sold out−13,600 |
Source: SEC EDGAR, Form 13F-HR, accession 0001012975-26-000761 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.